This agreement is a significant step for Aditxt as it expands its portfolio to include innovative therapies for infectious diseases;
Aditxt will partner with global logistics leader Agility to. | April 20, 2023
17.04.2023 - Aditxt, Inc, (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding its three innovation . Seite 1
Tetra and Cellvera to jointly develop an orally administered treatment, ARDS-003, in combination with the proven broad-spectrum antiviral, Qifenda 400MG.
Toronto Stocks Slide; Titan Mining Jumps on Permits for New York State Mine morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.